UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$469M |
| 2 |
Fidelity National Information Services
FIS
|
+$352M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$337M |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$316M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.92B |
| 2 |
UBS Group
UBS
|
+$1.46B |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$547M |
| 4 |
Microsoft
MSFT
|
+$461M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.47% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 5.76% |
| 5 | Industrials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOR
3901
Source Capital
SOR
$385M
| $1.06M | ﹤0.01% |
29,160
-2,732
| -9% | -$99.1K |
|
3902
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$106M
| $1.06M | ﹤0.01% |
33,543
-192
| -0.6% | -$6.16K |
|
|
AVYA
3903
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.06M | ﹤0.01% |
103,395
+76,987
| +292% | +$904K |
|
|
IMGN
3904
DELISTED
Immunogen Inc
IMGN
| $1.06M | ﹤0.01% |
436,613
+347,353
| +389% | +$922K |
|
3905
Levi Strauss
LEVI
$9.39B
| $1.06M | ﹤0.01% |
55,436
+38,891
| +235% | +$721K |
|
3906
Vanda Pharmaceuticals
VNDA
$302M
| $1.05M | ﹤0.01% |
79,388
+73,046
| +1,152% | +$1.02M |
|
|
HEQ
3907
John Hancock Hedged Equity & Income Fund
HEQ
$140M
| $1.05M | ﹤0.01% |
76,102
+6,565
| +9% | +$91.2K |
|
|
NXJ
3908
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $1.05M | ﹤0.01% |
72,653
+6,988
| +11% | +$101K |
|
3909
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
| $1.05M | ﹤0.01% |
20,537
+2,246
| +12% | +$115K |
|
3910
Utah Medical Products
UTMD
$225M
| $1.05M | ﹤0.01% |
10,966
+2,735
| +33% | +$254K |
|
3911
Zymeworks
ZYME
$1.67B
| $1.05M | ﹤0.01% |
42,367
+40,476
| +2,140% | +$1.01M |
|
|
I
3912
PUT
DELISTED
INTELSAT S. A.
I
| $1.05M | ﹤0.01% |
+46,100
| New | +$973K |
|
3913
Pilgrim's Pride
PPC
$6.54B
| $1.05M | ﹤0.01% |
32,783
+13,679
| +72% | +$397K |
|
|
HBI
3914
PUT
DELISTED
Hanesbrands
HBI
| $1.05M | ﹤0.01% |
+68,300
| New | +$1.04M |
|
3915
iShares Global Utilities ETF
JXI
$311M
| $1.05M | ﹤0.01% |
17,925
-352
| -2% | -$19.6K |
|
3916
Anixa Biosciences
ANIX
$116M
| $1.04M | ﹤0.01% |
261,043
+27,300
| +12% | +$114K |
|
|
BRFS
3917
DELISTED
BRF SA
BRFS
| $1.04M | ﹤0.01% |
113,991
-4,164
| -4% | -$37.9K |
|
3918
First Busey Corp
BUSE
$2.56B
| $1.04M | ﹤0.01% |
41,263
+29,064
| +238% | +$745K |
|
3919
DaVita
DVA
$11.7B
| $1.04M | ﹤0.01% |
18,270
-53,227
| -74% | -$3.09M |
|
3920
PUT
Steel Dynamics
STLD
$37.6B
| $1.04M | ﹤0.01% |
35,000
| – | – |
|
|
SGEN
3921
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.04M | ﹤0.01% |
+12,200
| New | +$894K |
|
3922
Molina Healthcare
MOH
$10.3B
| $1.04M | ﹤0.01% |
9,460
-2,319
| -20% | -$300K |
|
3923
Northern Oil and Gas
NOG
$2.35B
| $1.04M | ﹤0.01% |
52,892
-4,713
| -8% | -$86.6K |
|
|
PFD
3924
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
| $1.04M | ﹤0.01% |
69,486
-587
| -0.8% | -$8.82K |
|
|
BHR
3925
Braemar Hotels & Resorts
BHR
$142M
| $1.03M | ﹤0.01% |
111,231
+103,988
| +1,436% | +$943K |
|
Similar funds
UBS Group's Q3 2019 Portfolio in Review
As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2019 filing shows 737 new, 4,060 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
- UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
- UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
- UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
- UBS Group opened 737 new positions and closed 594 in Q3 2019.
- UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.